Singapore markets open in 5 hours 19 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
437.11+8.52 (+1.99%)
As of 03:40PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close428.59
Open431.00
Bid436.74 x 100
Ask437.53 x 100
Day's range428.62 - 439.15
52-week range320.01 - 448.40
Volume644,507
Avg. volume1,023,132
Market cap113.149B
Beta (5Y monthly)0.39
PE ratio (TTM)28.33
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Jennifer Schneider Elected to Vertex Board of Directors

    BOSTON, May 15, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director. Dr. Schneider has more than two decades of experience in the health care industry as a physician, scientist and health care executive. She co-founded and serves as Chief Executive Officer of Homeward Health, a company committed to rearchitecting the delivery of health and care for nearly 60 million Ame

  • Business Wire

    Vertex Reports First Quarter 2024 Financial Results

    BOSTON, May 06, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 financial guidance.

  • Business Wire

    Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older

    LONDON, April 26, 2024--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R.